A random forest model predicts responses to infliximab in Crohn’s disease based on clinical and serological parameters
Yong Li, Jianfeng Pan, Nan Zhou, Dongni Fu, Guanghui Lian, J. Yi, Yuyao Peng, Xiaowei Liu
Scandinavian Journal of Gastroenterology